Abdera Therapeutics News and Activities
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Abdera Therapeutics
- Lori Lyons-Williams, Director, President and Chief Executive Offic...
- Yvonne Yamanaka, Director
- Joel Drewry, Director
Create your alert
to follow the executive moves at Abdera Therapeutics.
Biotechnology
Abdera Therapeutics has 2,337 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).
Popular M&A news in Biotechnology
- The new name of Garuda Therapeutics is Stratus Therapeutics. (posted on May 12 2025).
- Jade Biosciences and Aerovate Therapeutics have announced they will merge (posted on April 30 2025)..
- Deepull has just announced a $50 Million fundraising (posted on April 29 2025).
Popular contacts in Biotechnology
News
Press releases by Abdera Therapeutics
- Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine Carcinoma • Abdera
- Fierce Biotech Names Abdera Therapeutics a “Fierce 15” Biotech Company of 2024 • Abdera
- Abdera Therapeutics Announces FDA Fast Track Designation for ABD-147, a Next-Generation Precision Radiopharmaceutical Therapy, for the Treatment of Patients with Extensive-stage Small Cell Lung Cancer • Abdera
- Abdera Therapeutics Announces FDA Clearance of IND Application for ABD-147 • Abdera
- Abdera Therapeutics Expands Management Team and Board of Directors • Abdera
- Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer • Abdera
- View more press releases Close
Social media about Abdera Therapeutics
- Abdera Therapeutics on Wikipedia, Google News & Yahoo Finance
- Abdera Therapeutics on LinkedIn, Twitter & YouTube
